LONDON, January 31, 2018 /PRNewswire/ --
PharmaBoardroom today releases its new 45-page Healthcare & Life SciencesReview Canada 2018.
With economic prosperity, political stability and significant growth prospects, Canada has much to admire. However, in the healthcare arena, despite a universal healthcare system, Canadians
This report explores the various avenues being explored to remedy these discrepancies; on the innovation side this includes state R&D investment initiatives, the associations calling for increased and more productive inter-stakeholder dialogue, and the new strategies of the major global players implanted in Canada. Also featured are the movers and shakers among Canada's broad spectrum of local companies; from generics manufacturers to biotechs and service providers, whose work is helping the nation regain its place at the top table of global healthcare and life sciences.
The report features in-depth interviews with:
"Canadian collaboration between industry and academia is generating new breakthrough ideas, therapies and technologies that are bringing new solutions to the market and benefiting Canadians and people all over the world" - Ginette Petitpas Taylor, Minister of Health
"We have seen new investments in early stage R&D and science, but innovation is more than just funding early or even applied research. It is walking the talk and adopting innovations when they are developed" - Peter Brenders, Sanofi Genzyme
"Over the past 17 years, the industry has moved from a 'one-size-fits-all' philosophy of drug treatment to a much more personalized approach" - Ronnie Miller, Roche
Click here to register and download the report.
Subscribe to our Free Newsletters!
Palliative care is a specialized multifaceted care for patients with chronic or terminal illness to ...
Our kitchen and food has the best medicinal properties to fight stress. These are the top 10 foods ...
Unripe green papaya fruit is a rich source of important nutrients including vitamins, proteins, & ...View All